(Q35798809)

10 August 2017

title

Imatinib mesylate treatment in two patients with idiopathic hypereosinophilic syndrome (English)

1 reference

hypereosinophilic syndrome

10 August 2017

1 reference

1 reference

Sonja M Payne

1

1 reference

10 August 2017

Michael J Kovacs

series ordinal

2

1 reference

10 August 2017

language of work or name

English

0 references

publication date

8 June 2004

1 reference

Annals of Pharmacotherapy

10 August 2017

published in

1 reference

10 August 2017

volume

38

1 reference

10 August 2017

issue

7-8

1 reference

10 August 2017

page(s)

1215-1218

1 reference

The hypereosinophilic syndrome: analysis of fourteen cases with review of the literature

10 August 2017

cites work

1 reference

The hypereosinophilic syndrome revisited

21 January 2018

1 reference

Response of idiopathic hypereosinophilic syndrome to treatment with imatinib mesylate

21 January 2018

1 reference

Imatinib therapy for hypereosinophilic syndrome and other eosinophilic disorders

21 January 2018

1 reference

A tyrosine kinase created by fusion of the PDGFRA and FIP1L1 genes as a therapeutic target of imatinib in idiopathic hypereosinophilic syndrome

21 January 2018

1 reference

Pharmacology of imatinib (STI571).

21 January 2018

1 reference

Imatinib: the first 3 years

21 January 2018

1 reference

Chronic Myeloid Leukemia — Advances in Biology and New Approaches to Treatment

21 January 2018

1 reference

Treatment of hypereosinophilic syndrome with imatinib mesilate

21 January 2018

1 reference

Efficacy of imatinib mesylate in the treatment of idiopathic hypereosinophilic syndrome

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1345/APH.1D505

1 reference

10 August 2017

1 reference